Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials
Alzheimers Dement
.
2016 May;12(5):631-2.
doi: 10.1016/j.jalz.2016.04.001.
Authors
Stacie Weninger
1
,
Maria C Carrillo
2
,
Billy Dunn
3
,
Paul S Aisen
4
,
Randall J Bateman
5
,
Joanne D Kotz
6
,
Jessica B Langbaum
7
,
Susan L Mills
5
,
Eric M Reiman
7
,
Reisa Sperling
8
,
Anna M Santacruz
5
,
Pierre N Tariot
7
,
Kathleen A Welsh-Bohmer
9
Affiliations
1
F-Prime Biomedical Research Initiative, Cambridge, MA, USA. Electronic address:
[email protected]
.
2
Medical & Scientific Relations Division, Alzheimer's Association, Chicago, IL, USA. Electronic address:
[email protected]
.
3
Division of Neurology Products, U.S. Food and Drug Administration, Silver Spring, MD, USA.
4
University of Southern California Alzheimer's Therapeutic Research Institute, San Diego, CA, USA.
5
Department of Neurology, Washington University, St Louis, MO, USA.
6
F-Prime Biomedical Research Initiative, Cambridge, MA, USA.
7
Banner Alzheimer's Institute, Phoenix, AZ, USA.
8
Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
9
Departments of Neurology & Psychiatry, Duke University, Durham, NC, USA.
PMID:
27157073
PMCID:
PMC5111162
DOI:
10.1016/j.jalz.2016.04.001
No abstract available
MeSH terms
Alzheimer Disease / prevention & control*
Biomarkers
Clinical Trials as Topic*
Cooperative Behavior*
Data Collection / standards
Drug Evaluation, Preclinical
Humans
Information Dissemination / methods*
Substances
Biomarkers
Grants and funding
K24 AG035007/AG/NIA NIH HHS/United States
R01 AG046179/AG/NIA NIH HHS/United States
UF1 AG046150/AG/NIA NIH HHS/United States
RF1 AG041705/AG/NIA NIH HHS/United States
P30 AG019610/AG/NIA NIH HHS/United States
U01 AG042791/AG/NIA NIH HHS/United States